748
Views
15
CrossRef citations to date
0
Altmetric
Research Paper

Hypoxia-mediated miR-212-3p downregulation enhances progression of intrahepatic cholangiocarcinoma through upregulation of Rab1a

, &
Pages 984-993 | Received 12 Feb 2018, Accepted 19 Mar 2018, Published online: 14 May 2018

References

  • Ebata T, Ercolani G, Alvaro D, Ribero D, Di Tommaso L, Valle JW. Current Status on Cholangiocarcinoma and Gallbladder Cancer. Liver Cancer. 2016;6(1):59–65. doi:10.1159/000449493. PMID:27995089.
  • Global Burden of Disease Cancer C. The Global Burden of Cancer 2013. JAMA Oncol. 2015;1(4):505–27. doi:10.1001/jamaoncol.2015.0735. PMID:26181261.
  • Banales JM, Cardinale V, Carpino G, Marzioni M, Andersen JB, Invernizzi P, Lind GE, Folseraas T, Forbes SJ, Fouassier L, et al. Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol. 2016;13(5):261–80. doi:10.1038/nrgastro.2016.51. PMID:27095655.
  • Chong DQ, Zhu AX. The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets. Oncotarget. 2016;7(29):46750–67. doi:10.18632/oncotarget.8775.
  • Lazaridis KN, Gores GJ. Cholangiocarcinoma. Gastroenterology. 2005;128(6):1655–67. doi:10.1053/j.gastro.2005.03.040. PMID:15887157.
  • Rizvi S, Gores GJ. Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma. Gastroenterology. 2013;145(6):1215–29. doi:10.1053/j.gastro.2013.10.013. PMID:24140396.
  • Seabra MC, Brown MS, Slaughter CA, Südhof TC, Goldstein JL. Purification of component A of Rab geranylgeranyl transferase: Possible identity with the choroideremia gene product. Cell. 1992;70(6):1049–57. doi:10.1016/0092-8674(92)90253-9. PMID:1525821.
  • Tisdale EJ BJ, Khosravi-Far R, Der CJ, Balch WE. GTP-binding mutants of rab1 and rab2 are potent inhibitors of vesicular transport from the endoplasmic reticulum to the Golgi complex. J Cell Biol. 1992;119(4):749–61. doi:10.1083/jcb.119.4.749. PMID:1429835.
  • Shimada K, Uzawa K, Kato M, Endo Y, Shiiba M, Bukawa H, Yokoe H, Seki N, Tanzawa H. Aberrant expression of RAB1A in human tongue cancer. Br J Cancer.. 2005;92(10):1915–21. doi:10.1038/sj.bjc.6602594. PMID:15870709.
  • Sun T, Wang X, He HH, Sweeney CJ, Liu SX, Brown M, Balk S, Lee GS, Kantoff PW. MiR-221 promotes the development of androgen independence in prostate cancer cells via downregulation of HECTD2 and RAB1A. Oncogene. 2014;33(21):2790–800. doi:10.1038/onc.2013.230. PMID:23770851.
  • Kim SJ, Sohn I, Do I-G, Jung SH, Ko YH, Yoo HY, Paik S, Kim WS. Gene expression profiles for the prediction of progression-free survival in diffuse large B cell lymphoma: Results of a DASL assay. Ann Hematol. 2014;93(3):437–47. doi:10.1007/s00277-013-1884-0. PMID:23975159.
  • Yang Y, Hou N, Wang X, Wang L, Chang Se, He K, Zhao Z, Zhao X, Song T, Huang C. miR-15b-5p induces endoplasmic reticulum stress and apoptosis in human hepatocellular carcinoma, both in vitro and in vivo, by suppressing Rab1A. Oncotarget. 2015;6(18):16227–38. doi:10.18632/oncotarget.3970. PMID:26023735.
  • Xu B-H, Li X-X, Yang Y, Zhang M-Y, Rao H-L, Wang H-Y, Zheng XF. Aberrant amino acid signaling promotes growth and metastasis of hepatocellular carcinomas through Rab1A-dependent activation of mTORC1 by Rab1A. Oncotarget. 2015;6(25):20813–28. doi:10.18632/oncotarget.5175. PMID:26308575.
  • Thomas JD, Zhang Y, Wei Y, Cho J-H, Morris LE, Wang H-Y, Zheng XF. Rab1A Is an mTORC1 Activator and a Colorectal Oncogene. Cancer Cell. 2014;26(5):754–69. doi:10.1016/j.ccell.2014.09.008. PMID:25446900.
  • Wang X, Liu F, Qin X, Huang T, Huang B, Zhang Y, Jiang B. Expression of Rab1A is upregulated in human lung cancer and associated with tumor size and T stage. Aging (Albany NY). 2016;8(11):2790–8. doi:10.18632/aging.101087. PMID:27902464.
  • Xu H, Qian M, Zhao B, Wu C, Maskey N, Song H, Li D, Song J, Hua K, Fang L. Inhibition of RAB1A suppresses epithelial-mesenchymal transition and proliferation of triple-negative breast cancer cells. Oncology Rep. 2017;37(3):1619–26. doi:10.3892/or.2017.5404.
  • Zhang CZ, Cao Y, Fu J, Yun J-P, Zhang M-F. miRߚ634 exhibits antiߚtumor activities toward hepatocellular carcinoma via Rab1A and DHX33. Mol Oncol. 2016;10(10):1532–41. doi:10.1016/j.molonc.2016.09.001. PMID:27693040.
  • Yang XZ, Li XX, Zhang YJ, Rodriguez-Rodriguez L, Xiang MQ, Wang HY, Zheng XF. Rab1 in cell signaling, cancer and other diseases. Oncogene. 2016;35(44):5699–704. doi:10.1038/onc.2016.81. PMID:27041585.
  • Murray AW. Recycling the Cell Cycle: Cyclins Revisited. Cell. 2004;116(2):221–34. doi:10.1016/S0092-8674(03)01080-8. PMID:14744433.
  • Sears RC, Nevins JR. Signaling Networks That Link Cell Proliferation and Cell Fate. J Biol Chem. 2002;277(14):11617–20. doi:10.1074/jbc.R100063200. PMID:11805123.
  • Nieto MA, Cano A. The epithelial–mesenchymal transition under control: Global programs to regulate epithelial plasticity. Semin Cancer Biol. 2012;22(5–6):361–8. doi:10.1016/j.semcancer.2012.05.003. PMID:22613485.
  • Guarino M, Rubino B, Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology. Pathology. 2007;39(3):305–18. doi:10.1080/00313020701329914. PMID:17558857.
  • He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5:522. doi:10.1038/nrg1379. PMID:15211354.
  • Hackenbeck T, Huber R, Schietke R, Knaup KX, Monti J, Wu X, Klanke B, Frey B, Gaipl U, Wullich B, et al. The GTPase RAB20 is a HIF target with mitochondrial localization mediating apoptosis in hypoxia. Biochim Biophys Acta (BBA)–Mol Cell Res. 2011;1813(1):1–13. doi:10.1016/j.bbamcr.2010.10.019.
  • Wang T, Gilkes DM, Takano N, Xiang L, Luo W, Bishop CJ, Chaturvedi P, Green JJ, Semenza GL. Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis. Proc Natl Acad Sci U S A. 2014;111(31):E3234–E42. doi:10.1073/pnas.1410041111. PMID:24938788.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.